Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Analyst picks & changes

Aastrom Biosciences Inc.

(ASTM), Ann Arbor, Mich.

Business: Gene/Cell therapy

Cowen & Co. analyst David Stone lowered his

Read the full 181 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE